Abstract

This article deals with fixed-width confidence intervals of log odds ratio for correlated setup in crossover design. Related asymptotics are obtained. Procedures are evaluated by simulations, followed by a data study.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Crossover or parallel design in infertility trials? The discussion continues
Egbert R te Velde ... J.Dik F Habbema
Fertility and Sterility | VOL. 70
Egbert R te Velde, et. al.Egbert R te Velde ... J.Dik F Habbema
01 Jul 1998
Implications of bioequivalence testing are also described by Patterson and so we do not repeat these here. At the present time average bioequivalence (see Section 7.2) serves as the current international standard for bioequivalence testing using a 2× 2 cross-over design. Alternative designs (e.g., replicate cross-over designs) may be also utilized for drug products to improve power (see Section 7.6). We will consider population and individual bioequivalence testing as these utilize cross-over study designs and were the subject of extensive debate in the 1990s (see Patterson, 2001b, for a summary), but these may not currently be used for access to the marketplace (FDA Guidance, 2002). 7.2 Testing for average bioequivalence The now generally accepted method of testing for ABE is the two-one-sided-tests procedure (TOST) proposed by Schuirmann (1987). It is con-veniently done using a confidence interval calculation. Let µ be the (true) mean values of log(AUC) (or log(Cmax)) when subjects are treated with T and R, respectively. ABE is demonstrated if the 90% two-sided confidence interval for µ falls within the acceptance limits of − ln 1.25 = −0.2231 and + ln 1.25 = 0.2231. These limits are set by the regulator (FDA Guid-ance, 1992, 2001, 2002) and when exponentiated give limits of 0.80 and 1.25. That is, on the natural scale ABE is demonstrated if there is good evidence that: 0.80 ≤ exp(µ ) ≤ 1.25. We note that symmetry of the confidence interval is on the logarithmic scale, not the natural scale. The method gets its name (TOST) because the process of deciding if the 90% confidence interval lies within the acceptance limits is equiva-lent to rejecting both of the following one-sided hypotheses at the 5% significance level: H :µ ≤− ln 1.25 H :µ ≥ ln 1.25. Example 7.1 The derived data given in Tables 7.1 and 7.2are from a pharmacoki-netic study that compared a test drug (T) with a known reference drug (R). The design used was a 2×2 cross-over with 24 healthy volunteers in the RT sequence group and 25 in the TR sequence group. Each volunteer should have provided both an AUC and Cmax value. However, as can
-
-
--
12 Mar 2003
A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema
Richard W.J. Lee ... Darby J.S. Thompson
Ophthalmology | VOL. 123
Richard W.J. Lee, et. al.Richard W.J. Lee ... Darby J.S. Thompson
10 Feb 2016
Videolaryngoscopy versus direct laryngoscopy for adult patients requiring tracheal intubation.
Sharon R Lewis ... Tim M Cook
The Cochrane database of systematic reviews | VOL. 11
Sharon R Lewis, et. al.Sharon R Lewis ... Tim M Cook
15 Nov 2016
View more papers

More From: Sequential Analysis

Paper Title
Journal
Date
Author
A two armed optimal response adaptive randomization for ordinal categorical responses with possible misclassification
Soumyadeep Das
Sequential Analysis | VOL. ahead-of-print
Soumyadeep DasSoumyadeep Das
04 Jan 2024
Estimation of fixed-accuracy confidence interval of the stress–strength reliability for inverse Pareto distribution using two-stage sampling technique
Neeraj Joshi ... Sudeep R. Bapat
Sequential Analysis | VOL. 43
Neeraj Joshi, et. al.Neeraj Joshi ... Sudeep R. Bapat
16 Dec 2023
Control charts for high-dimensional time series with estimated in-control parameters
Rostyslav Bodnar ... Taras Bodnar
Sequential Analysis | VOL. 43
Rostyslav Bodnar, et. al.Rostyslav Bodnar ... Taras Bodnar
16 Dec 2023
Truncated sequential change-point detection for Markov chains with applications in the epidemic statistical analysis
Evgenii A. Pchelintsev ... Roman O. Tenzin
Sequential Analysis | VOL. 43
Evgenii A. Pchelintsev, et. al.Evgenii A. Pchelintsev ... Roman O. Tenzin
16 Dec 2023
View more papers